Evanthia Galanis

1997–2025 年に発表

127
論文数
23,909
被引用数
80
h 指数
125
i10 指数

被引用数

Evanthia Galanis の年別被引用数1986 年: 被引用 1 件1993 年: 被引用 1 件1998 年: 被引用 3 件1999 年: 被引用 5 件2000 年: 被引用 7 件2001 年: 被引用 10 件2002 年: 被引用 13 件2003 年: 被引用 32 件2004 年: 被引用 29 件2005 年: 被引用 41 件2006 年: 被引用 66 件2007 年: 被引用 78 件2008 年: 被引用 90 件2009 年: 被引用 100 件2010 年: 被引用 113 件2011 年: 被引用 174 件2012 年: 被引用 140 件2013 年: 被引用 160 件2014 年: 被引用 141 件2015 年: 被引用 155 件2016 年: 被引用 158 件2017 年: 被引用 215 件2018 年: 被引用 183 件2019 年: 被引用 664 件2020 年: 被引用 962 件2021 年: 被引用 987 件2022 年: 被引用 933 件2023 年: 被引用 703 件2024 年: 被引用 1,261 件2025 年: 被引用 593 件2026 年: 被引用 22 件1987〜1992 年は被引用が無いため表示していません1994〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,009 件、この内訳の 29.1%中国: 引用元論文 872 件、この内訳の 8.4%ドイツ: 引用元論文 804 件、この内訳の 7.8%イギリス: 引用元論文 551 件、この内訳の 5.3%イタリア: 引用元論文 524 件、この内訳の 5.1%カナダ: 引用元論文 411 件、この内訳の 4%フランス: 引用元論文 400 件、この内訳の 3.9%オランダ: 引用元論文 379 件、この内訳の 3.7%スイス: 引用元論文 358 件、この内訳の 3.5%スペイン: 引用元論文 253 件、この内訳の 2.4%日本: 引用元論文 200 件、この内訳の 1.9%韓国: 引用元論文 200 件、この内訳の 1.9%
0%29.1%その他 23%

分野

  • Medicine64%
  • Biochemistry, Genetics and Molecular Biology25%
  • Immunology and Microbiology2.7%
  • Neuroscience2.4%
  • Materials Science1.7%
  • Engineering1.5%
  • その他2.7%

トピック

  • Glioma Diagnosis and Treatment15.8%
  • Brain Metastases and Treatment7.3%
  • Virus-based gene therapy research3.6%
  • Meningioma and schwannoma management3.1%
  • Radiomics and Machine Learning in Medical Imaging2.7%
  • CAR-T cell therapy research2.4%
  • その他65.1%

共著者

全論文

検索で開く
  1. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Taphoorn, Joerg-Christian Tonn, Jonathan Tsang, Roel G.W. Verhaak, Andreas von Deimling, Wolfgang Wick, Gelareh Zadeh, David A. Reardon, Kenneth Aldape, Martin J. van den Bent - Neuro-Oncology 2020 被引用: 1,137

  2. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 被引用: 3,829

  3. RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 462

  4. Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

    著者: , , , , , , , , , , , , , , , , - Neuro-Oncology 2017 被引用: 699

  5. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases

    著者: , , , , , , , , , , , , , , , , - JAMA 2016 被引用: 1,661

  6. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 被引用: 1,192

  7. Glioblastoma

    著者: , , - Handbook of clinical neurology 2016 被引用: 474

  8. Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2015 被引用: 665

  9. Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement

    著者: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 被引用: 164

  10. Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases

    著者: , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2020 被引用: 259

  11. Liquid biopsy in gliomas: A RANO review and proposals for clinical applications

    著者: , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2022 被引用: 134

  12. Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2024 被引用: 68

  13. BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 被引用: 135

  14. Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group

    著者: , , , , , , , , , , , , , , , , , - Neuro-Oncology 2018 被引用: 205

  15. Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chas Haynes - Neuro-Oncology 2020 被引用: 191

  16. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adam L. Cohen, Shivangi Vora, Michael V. Knopp, Ian F. Dunn, Priya Kumthekar, Jann N. Sarkaria, Susan M. Geyer, Xiomara W. Carrero, Maria Martinez‐Lage, Daniel P. Cahill, Paul D. Brown, Caterina Giannini, Sandro Santagata, Frederick G. Barker, Evanthia Galanis - Journal of Clinical Oncology 2022 被引用: 105

  17. The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria

    著者: , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2017 被引用: 244

  18. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katharine J. Drummond, Ian F. Dunn, Evanthia Galanis, Caterina Giannini, Roland Goldbrunner, Brent Griffith, Rintaro Hashizume, C. Oliver Hanemann, Christel Herold‐Mende, Craig Horbinski, Raymond Y. Huang, David H. James, Michael D. Jenkinson, Christine Jungk, Timothy J Kaufman, Boris Krischek, Daniel H. Lachance, Christian la Fougère, Ian Lee, Jeff C. Liu, Yasin Mamatjan, Tathiane M. Malta, Christian Mawrin, Michael McDermott, David G. Muñoz, Farshad Nassiri, Houtan Noushmehr, Ho‐Keung Ng, Arie Perry, Farhad Pirouzmand, Laila Poisson, Bianca Pollo, David R. Raleigh, Felix Sahm, Andrea Saladino, Thomas Santarius, Christian Schichor, David Schultz, Nils Ole Schmidt, Warren R. Selman, Andrew E. Sloan, Julian Spears, James M. Snyder, Suganth Suppiah, Ghazaleh Tabatabai, Marcos Tatagiba, Daniela Pretti da Cunha Tirapelli, J. C. Tonn, Derek S. Tsang, Michael A. Vogelbaum, Andreas von Deimling, Patrick Y. Wen, Tobias Walbert, Manfred Westphal, Adriana M Workewych, Gelareh Zadeh, Gelareh Zadeh, Kenneth Aldape - Neuro-Oncology 2019 被引用: 274

  19. Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tracy T. Batchelor, Michael Weller, Michael A. Vogelbaum, Matthias Preusser, Mitchel S. Berger, Mustafa Khasraw - Nature Medicine 2023 被引用: 53

  20. Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daphne A. Haas‐Kogan, Shyam Tanguturi, Daniel Cagney, Ayal A. Aizer, Lisa Doherty, Maria Lavallee, Brittany Fisher-Longden, Shanna Dowling, Jack Geduldig, Fiona Watkinson, William Pisano, Seth Malinowski, Shakti Ramkissoon, Sandro Santagata, David M. Meredith, E. Antonio Chiocca, David A. Reardon, Brian M. Alexander, Keith L. Ligon, Patrick Y. Wen - Journal of Clinical Oncology 2023 被引用: 50

  21. Systematic review of combinations of targeted or immunotherapy in advanced solid tumors

    著者: , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2021 被引用: 81

  22. Imaging and diagnostic advances for intracranial meningiomas

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christel Herold‐Mende, Craig Horbinski, Raymond Y Huang, David James, Michael D. Jenkinson, Christine Jungk, Timothy J Kaufman, Boris Krischek, Daniel H. Lachance, Christian la Fougère, Ian Lee, Jeff C. Liu, Yasin Mamatjan, Alireza Mansouri, Christian Mawrin, Michael McDermott, David G. Muñoz, Farshad Nassiri, Houtan Noushmehr, Ho‐Keung Ng, Arie Perry, Farhad Pirouzmand, Laila Poisson, Bianca Pollo, David R. Raleigh, Felix Sahm, Andrea Saladino, Thomas Santarius, Christian Schichor, David Schultz, Nils Ole Schmidt, Warren R. Selman, Andrew E. Sloan, Julian Spears, James Snyder, Suganth Suppiah, Ghazaleh Tabatabai, Marcos Tatagiba, Daniela Pretti da Cunha Tirapelli, J. C. Tonn, Derek S. Tsang, Michael A. Vogelbaum, Andreas von Deimling, Patrick Y Wen, Tobias Walbert, Manfred Westphal, Adriana M Workewych, Gelareh Zadeh - Neuro-Oncology 2018 被引用: 189

  23. A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K

    著者: , , , , , , , , , , , , , , - Neuro-Oncology 2014 被引用: 166

  24. Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02

    著者: , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2017 被引用: 134